Login to Your Account

Inspire Drops Bilastine, but all Eyes are on Denufosol

By Trista Morrison

Tuesday, January 15, 2008
Inspire Pharmaceuticals Inc.'s decision to discontinue development of the oral antihistamine bilastine for allergic rhinitis was "no surprise" to Cowen & Co. analyst Ian Sanderson. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription